Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
B2Pharma is an Italian pharmaceutical and nutraceutical company founded in 2014 as a spin-off of IDIPharma. The company specializes in the research, development, and commercialization of innovative therapeutic solutions and dietary supplements, with a primary focus on neuro-rehabilitation, orthopedics, physiatry, and uro-gynecology. B2Pharma's product portfolio includes notable brands such as Neurodine, Saffril, TendoGenIAL, and B2Vein, which utilize high-quality active ingredients like palmitoylethanolamide, collagen, and botanical extracts to improve patient well-being. The company operates nationwide in Italy through a structured distribution network and collaborates closely with medical specialists to address niche therapeutic needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on B2Pharma.